Bacterial Keratitis. Part 1. Epidemiology, Etiology, Pathophysiology, Risk Factors, Clinic, Current Aspects of Diagnosis
https://doi.org/10.18008/1816-5095-2023-1-17-23
Abstract
Bacterial keratitis is an urgent problem in ophthalmology, representing a threatening condition for the anatomy and function of the eyeball. The disease is widespread and varies significantly depending on the geographical region, even within the same country. The BC clinic is well-known, has been studied in sufficient detail, but in real practice it often causes significant difficulties in diagnosis, since it largely resembles a keratitis clinic of another etiology. A significant role in the differential diagnosis of these diseases is played by laboratory tests, which are not always available and easy to perform and implement. The results of the bacteriological analysis have a delayed period, which may be critical for determining the correct treatment tactics, but, nevertheless, the information that can be obtained about the microbe and its sensitivity to ABP makes it possible to better cope with the infectious process. The development and introduction of new laboratory research methods into modern clinical practice is very relevant, could simplify and speed up the diagnosis of the disease, and with it increase the effectiveness of its treatment.
About the Authors
O. V. ShilovskikhRussian Federation
Shilovskikh Oleg V. - PhD, ophthalmic surgeon, chief freelance ophthalmologist of the Sverdlovsk region, general director
Academician Bardin str., 4A, Yekaterinburg, 620149, Russia
V. O. Ponomarev
Russian Federation
Ponomarev Vyacheslav O. - PhD, ophthalmic surgeon, deputy general director for scientific and clinical work
Academician Bardin str., 4A, Yekaterinburg, 620149, Russia
V. N. Kazaykin
Russian Federation
Kazaykin Viktor N. - MD, ophthalmic surgeon, leading researcher
Academician Bardin str., 4A, Yekaterinburg, 620149, Russia
K. A. Tkachenko
Russian Federation
Tkachenko Konstantin A. - ophthalmologist
Academician Bardin str., 4A, Yekaterinburg, 620149, Russia
N. S. Demchenko
Russian Federation
Demchenko Nadezhda S. - PhD, doctor of Clinical laboratory diagnostics
Academician Bardin str., 4A, Yekaterinburg, 620149, Russia
References
1. Demarco B., Chen K.W., Broz P. Cross talk between intracellular pathogens and cell death. Immunol. Rev. 2020;297:174–193. DOI: 10.1111/imr.12892
2. Dotsenko V.L., Nakhikyan R.I., Solovyova N.I., Platonova T.K., Yarovaya G.A. Proteolytic enzymes of lacrimal fluid as pathogenesis factors of chronic ulcers of the cornea of the eye. Medical chemistry issues = Voprosy medicinskoj himii. 1990;36(3):73–76 (In Russ.).
3. Mikhel V.D., Gorgiladze T.U. The use of an ectericide in combination with a pulsed electromagnetic field in the treatment of bacterial keratitis. Journal of Ophthalmology (Ukraine) = Ovtal’mologitscheckij zhurnal 1993;3:163–165 (In Russ.).
4. Sitnik G.V. Modern approaches to the treatment of corneal ulcers. Medical Journal = Medicinskiy zhurnal. 2007;4:100–104 (In Russ.).
5. Slonimsky Yu.B., Slonimsky S.Yu. ed. Avetisov S.E., Egorov E.A., Moshetova L.K., Neroev V.V., Takhchidi H.P. Ophthalmology. National leadership. 2nd edition, Moscow: GEOTAR-Media, 2022. Р. 464–465 (In Russ.).
6. Singh R.B., Das S., Chodosh J., Sharma N., Zegans M.E., Kowalski R.P., Jhanji V. Paradox of complex diversity: Challenges in the diagnosis and management of bacterial keratitis. Prog Retin Eye Res. 2022;88:101028. doi: 10.1016/j.preteyeres.2021.101028.
7. Bourcier T., Thomas F., Borderie V., Chaumeil C., Laroche L. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmology. 2003;87(7):834–838. DOI: 10.1136/bjo.87.7.834
8. Keay L, Edwards K, Naduvilath T, Taylor HR, Snibson GR, Forde K, Stapleton F. Microbial keratitis predisposing factors and morbidity. Ophthalmology. 2006;113(1):109–116. DOI: 10.1016/j.ophtha.2005.08.013
9. Ting DSJ, Ho CS, Deshmukh R, Said DG, Dua HS. Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance. Eye. 2021;35(4):1084–1101. DOI: 10.1038/s41433-020-01339-3
10. Maychuk Yu.F. Selection and dosing of antibiotics for bacterial corneal ulcers. Journal of Ophthalmology (Ukraine) = Ovtal’mologitscheckij zhurnal. 1990;8:502–506 (In Russ.).
11. Sharshkova M.A., Deev L.A. Results of bacteriological examination in patients with keratitis. Clinical microbiology and antimicrobial chemotherapy = Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2012;14(3):260–264 (In Russ.).
12. Starkov G.L., Sokolova R.C. On the epidemiology, prevention and clinical examination of ophthalmic patients with external inflammatory diseases. Annals of Ophthalmology = Vestnik oftal’mologii. 1988;104(1):3–5 (In Russ.).
13. Khoo P., Cabrera Aguas M., Nguyen V. Microbial keratitis in Sydney, Australia: risk factors, patient outcomes, and seasonal variation. Graefes Arch Clin Exp Ophthalmol. 2020;258:1745–1755. DOI: 10.1007/s00417-020-04681-0
14. Janumala H, Sehgal PK, Mandal B. ed. Dr. Muthiah Srinivasan. Bacterial Keratitis — Causes, Symptoms and Treatment, Keratitis, Rijeka: IntechOpen, 2012;15–29. DOI: 10.5772/34599
15. Maier P, Betancor PK, Reinhard T. Contact Lens Associated Keratitis–An Often Underestimated Risk. Deutsches Ärzteblatt International. 2022;119:669–674. DOI: 10.3238/arztebl.m2022.0281
16. Hall B.J., Jones L., Optom F.C. Contact Lens Cases: The Missing Link in Contact Lens Safety? Eye & Contact Lens: Science & Clinical Practice. 2010;36(2):101–105. DOI: 10.1097/ICL.0b013e3181d05555
17. Kaliamurthy J, Kalavathy CM, Parmar P, Jesudasan CAN, Thomas PA. Spectrum of Bacterial Keratitis at a Tertiary Eye Care Centre in India. BioMed Research International. 2013;181564. DOI: 10.1155/2013/181564
18. Gurnani B, Kaur K. Bacterial Keratitis. [Updated 2022 Dec 6]. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2022. https://www.ncbi.nlm.nih.gov/books/NBK574509/
19. Gurbaxani A, Baker M, Nash J. Antibiotic resistance in microbial keratitis: Ten-year experience of corneal scrapes in the United Kingdom. Ophthalmology. 2011;118(11):2161–2165. DOI: 10.1016/j.optha.2011.04.021
20. Babitha V, Jyothi PT. Microbiology for general ophthalmologists. Kerala Journal of Ophthalmology. 2017;29:72–78. DOI: 10.4103/kjo.kjo_58_17
21. Baranov A.A., Mayansky A.N., Chebotar I.V., Mayansky N.A. A new era in medical microbiology. Annals of the Russian academy of medical sciences = Vestnik Rossiyskoy akademii medicinskih nauk. 2015;85(1):1008–1016 (In Russ.).
22. Alonso B., Latorre M.K., Cruces R., Ampuero D., Haces L., Martin-Rabadan P., Sanchez Carrillo S., Rodriguez B., Buza E., Munoz P., Guembe M.Evaluation of the Alfred™ turbidity monitoring system (Alifax®) following sonication in the diagnosis of central venous catheter colonization. European Journal of Clinical Microbiology & Infectious Diseases. 2019;38(9):1737–1742. DOI: 10.1007/s10096-019-03606-у
23. Giordano S., Piccoli E., Brucculeri V., Bernini S. Prospective evaluation of two technologies of rapid phenotypic sensitivity to antimicrobials for the diagnosis of sepsis. BioMed Research International. 2018:6976923. DOI: 10.1155/2018/6976923
24. Boronina L.G., Samatova E.V. Application of laser light scattering technologies for the diagnosis of catheter-as-sociated patients. Russian Clinical Laboratory Diagnostics Journal = Klinicheskaja laboratornaja diagnostika. 2019;64(8):503–506 (In Riss.). DOI: 10.18821/0869-2084-2019-64-8-503-506
25. Romanowski JE, Nayyar SV, Romanowski EG, Jhanji V, Shanks RMQ, Kowalski RP. Speciation Antibiotic Susceptibilities of Coagulase Negative Staphylococci Isolated from Ocular Infections. Antibiotics. 2021;10(6):721. DOI: 10.3390/antibiotics10060721
26. Hernández-Durán M, López-Jácome LE, Colín-Castro CA. Comparison of the Microscan Walkaway Plus and VITEK 2 Compact systems for the identification and susceptibility of clinical Gram positive and Gram negative bacteria. Investigación en Discapacidad. 2017;6(3):105–114.
27. LaCroce SJ, Wilson MN, Romanowski JE, Newman JD, Jhanji V, Shanks RMQ, Kowalski RP. Moraxella nonliquefaciens and M. osloensis Are Important Moraxella Species That Cause Ocular Infections. Microorganisms. 2019;7(6):163. DOI: 10.3390/microorganisms7060163
28. I.V. Chebotar, O.A. Ponomarenko, A.V. Lazareva, O.V. Karaseva, A.L. Gorelik, Yu.A. Bocharova, R.F. Tepaev. The use of MALDI-TOF technology for the identification of causative agents of septic conditions in pediatric practice. Modern technologies in medicine = Sovremennye tekhnologii v мediciny. 2015;7(2):68–73 (In Russ.).
29. Cornwell E., Daniel R. Evaluation of matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI TOF MS) for the Identification of Group B Streptococcus. BMC Research. 2019;12:85. DOI: 10.1186/s13104-019-4119-1
30. Rohilla R, Meena S, Mohanty A, Gupta N, Kaistha N, Gupta P. Etiological spectrum of infectious keratitis in the era of MALDI TOF MS at a tertiary care hospital. Journal of Family Medicine and Primary Care. 2020;9(9):4576–4581. DOI: 10.4103/jfmpc.jfmpc_630_20
31. Boronina L.G. Samatova E.V. Kukushkina M.P. Asnovskaya A.G. Panova S.A. Ustyugova S.S. Search for a rational algorithm for testing carbapenemase in gram negative bacteria at the present stage. Problems in medical micolology = Problemy medicinskoj mikologii. 2021;23(2):62 (In Russ.).
32. Mascarenhas J, Lalitha P, Prajna NV. Acanthamoeba, fungal, and bacterial keratitis: a comparison of risk factors and clinical features. American Journal of Ophthalmology. 2014;157(1):56–62. DOI: 10.1016/j.ajo.2013.08.032
33. Centers for Disease Control and Prevention. Update: Fusarium keratitis-United States, 2005–2006. Morbidity and Mortality Weekly Report. 2006;55(20):563–564.
34. Centers for Disease Control and Prevention. Acanthamoeba keratitis multiple states, 2005–2007. Morbidity and Mortality Weekly Report. 2007;56(21):532–534.
35. Alfonso EC, Cantu Dibildox J, Munir WM. Insurgence of Fusarium keratitis associated with contact lens wear. Archives of Ophthalmology. 2006;124(7):941–947. DOI:
36. 1001/archopht.124.7.ecs60039
37. Bernal MD, Acharya NR, Lietman TM, Strauss EC, McLeod SD, Hwang DG. Outbreak of Fusarium keratitis in soft contact lens wearers in San Francisco. Archives of Ophthalmology. 2006;124(7):1051–1053. DOI: 10.1001/archopht.124.7.ecr60006
38. Chang DC, Grant GB, O’Donnell K. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. Journal of the American Medical Association. 2006;296(8):953–963. DOI: 10.1001/jama.296.8.953
39. Joslin CE, Tu EY, Shoff ME. The association of contact lens solution use and acanthamoeba keratitis. American Journal of Ophthalmology. 2007;144(2):169–180. DOI: 10.1016/j.ajo.2007.05.029
40. Khor WB, Aung T, Saw SM. An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. Journal of the American Medical Association. 2006;295(24):2867–2873. DOI: 10.1001/jama.295.24.2867
41. Margolis TP, Whitcher JP. Fusarium A new culprit in the contact lens case. Journal of the American Medical Association. 2006;296(8):985–987.
42. Saw SM, Ooi PL, Tan DT. Risk factors for contact lens related Fusarium keratitis: a case control study in Singapore. Archives of Ophthalmology. 2007;125(5):611–617. DOI: 10.1001/archopht.125.5.611
43. Thebpatiphat N, Hammersmith KM, Rocha FN. Acanthamoeba keratitis: a parasite on the rise. Cornea. 2007;26(6):701–706. DOI: 10.1097/ICO.0b013e31805b7e63
44. Lin A, Rhee MK, Akpek EK, Amescua G, Farid M, Garcia Ferrer FJ. Bacterial Keratitis Preferred Practice Pattern®. Ophthalmology. 2019;126(1):1–55.
45. Prabriputaloong T, Margolis TP, Lietman TM, Wong IG, Mather R, Gritz DC. Atopic disease and herpes simplex eye disease: a population-based case-control study. American Journal of Ophthalmology. 2006;142(5):745–749. DOI: 10.1016/j.ajo.2006.06.050
46. Avetisov E.S. Eye diseases. Fundamentals of ophthalmology: textbook / ed. V.G. Kopaeva. Moscow: Medicine; 2012. 552 p. (In Russ.).
47. Krachmer JN, Mannis MJ, Holland EJ. Cornea, E Book, Amsterdam: Elsevier, 2010. 924 p.
48. Romaniko O.M., Robman L.D. Therapeutic and tectonic keratoplasty for corneal ulcers. Journal of Ophthalmology (Ukraine) = Ovtal’mologitscheckiy zhurnal. 1983;2:83–86 (In Russ.).
49. Hayashi K., Frangieh G., Wolf G., Kenyon K.R. Expression of Transforming growth factor beta in wound healing of vitamin A deficient rat corneas. Investigative Ophthalmology and Visual Science. 1989;Feb:30(2):239–247.
50. Hirst L.W, Stallard K., Whitby M., Perrin R. Phialophora corneal ulcer. Australian and New Zealand Journal of Ophthalmology. 1995;23(3):223–225. DOI: 10.1111/j.1442-9071.1995.tb00162.x
51. Jones DB. Decision making in the management of microbial keratitis. Ophthalmology. 1981;88(8):814–820. DOI: 10.1016/s0161-6420(81)34943-4
52. Kijlstra A. The role of cytokines in ocular inflammation. British Journal of Ophthalmology. 1994;78(12):885–886. DOI: 10.1136/bjo.78.12.885
53. Read A.F., Woods R.J. Antibiotic resistance management. Evolution, Medicine and Public Health. 2014;14(1):147. DOI: 10.1093/emph/eou024
54. Bartlett J.G., Gilbert D.N., Spellberg B. Seven ways to preserve the miracle of antibiotics. Clinical Infectious Diseases. 2013;56(10):1445–1450. DOI: 10.1093/cid/cit070
55. Viswanathan V.K. Off-label abuse of antibiotics by bacteria. Gut Microbes. 2014;5(1):3–4. DOI: 10.4161/gmic.28027
56. Luyt C.E., Brechot N., Trouillet J.L., Chastre J. Antibiotic stewardship in the intensive care unit. Critical Care. 2014;18(5):480. DOI: 10.1186/s13054-014-0480-6
57. Michael C.A, Dominey-Howes D., Labbate M. The antibiotic resistance crisis: causes, consequences, and management. Frontiers in Public Health. 2014;2:145. DOI: 10.3389/fpubh.2014.00145
Review
For citations:
Shilovskikh O.V., Ponomarev V.O., Kazaykin V.N., Tkachenko K.A., Demchenko N.S. Bacterial Keratitis. Part 1. Epidemiology, Etiology, Pathophysiology, Risk Factors, Clinic, Current Aspects of Diagnosis. Ophthalmology in Russia. 2023;20(1):17-23. (In Russ.) https://doi.org/10.18008/1816-5095-2023-1-17-23